Location: Home > Pharma China Web Edition
  • search
  • go
  • Other News
    Upcoming Event: 3rd Biologics Manufacturing Asia 2016 10/14/2015
    Event: 3rd Biologics Manufacturing Asia 2016
    Dates: February 29 – March 1, 2016
    Venue: TBD, Singapore
    Contact: Sumukhi Sreevatsan
    Tel: +65 6493 2095
     
    We are very happy to announce that Pharma China is a supporting media partner at the 3rd Biologics Manufacturing Asia 2016 conference taking place in Singapore between the 29th of February and 1st of March 2016.
     
    Some of the confirmed speakers include:
    • Allison Moore, Senior Vice President, Process Development, Amgen, USA
    • Parimal Desai, VP,  Global Vaccines & Biologics Commercialization, Merck Manufacturing Division, USA
    • Senthil Ramaswamy, Director, MSAT, Lonza, Singapore
    • Srinivasan Raman, Vice President and Head of Biocon Malaysia Operations, Biocon Sdn BhD, Malaysia
    • Peter Turecek, ​Senior Director, Global Medical Affairs, Senior Scientific Advisor, BAXALTA AUSTRIA
    • Alois Jungbauer, Laboratory of Protein Technolog and Downstream Processing, AUSTRIAN CENTER OF BIOTECHNOLOGY, AUSTRIA
    • Villoo Patel, Chairman and Managing Director of Avesthagen, India
    • Ho Jung Oh, Viral Vaccines Team Leader, MINISTRY OF FOOD AND DRUG SAFETY, KOREA
    • Steffen Goletz, CEO, CSO, Glycotope GmbH, Germany
    • Wenshan Lee, Vice President, Process Development, Elevant Biopharma, Taiwan
    • Rudiger Mechnser, Principal Engineer, Samsung Engineering, Korea
    • Eric Tsao, Chief Executive Officer, Synermore, USA
    • Song Zhiwei, Principal Scientist, Bioprocessing Technology Institute, Singapore
    • Gyun Min Lee, Professor, Korea Advanced Institute of Science and Technology, Korea
    Some of the themes that would be discussed include:
    • Biomanufacturing Excellence: Flexible manufacturing, modular smart facilities, single use, shift from batch to continuous manufacturing, Novel technologies and how it will revolutionize biomanufacturing in the next few years.
    • Upstream Processing: Optimized large scale cell culture performance, high-throughput media selection and optimization, reducing cell-line characterization timelines.
    • Downstream Processing: Continuous DSP and process economy maximization, advances in downstream disposables, viral Clearance strategies & regulations.
    • PAT, QbD and automation of process design.
  • Site map | Contact Us | Links
  • © Wicon International Group